Form 4: Thermo Fisher Scientific Director James C. Mullen Reports Stock Transaction
SEC Form 4 Filing
Director James C. Mullen reported the acquisition and disposal of Thermo Fisher Scientific (TMO) common stock on May 22, 2024.
Summary
- On May 22, 2024, James C. Mullen, a director of Thermo Fisher Scientific Inc. (TMO), reported a transaction involving the company's common stock.
- Mullen acquired 339 shares of common stock.
- Mullen disposed of 0 shares of common stock.
- Following the reported transaction, Mullen beneficially owns 2,828 shares of Thermo Fisher Scientific Inc.
Sentiment
Score: 5
Explanation: This is a neutral report of a stock transaction by a company director. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of company directors and officers, which can sometimes provide insights into their perspectives on the company's prospects.
Stakeholder Impact
- The transaction may be of interest to shareholders as it provides insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 05/22/2024 | Date of stock transaction |
| 05/23/2024 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.